6-(3,4-Methylenedioxyphenyl)-3,5-hexadien-2-one



Compound IDCDAMM02444
Common name6-(3,4-Methylenedioxyphenyl)-3,5-hexadien-2-one
IUPAC name6-(1,3-benzodioxol-5-yl)hexa-3,5-dien-2-one
Molecular formulaC13H12O3

Experimental data

Retention time9.88
Adduct[M+NH4]+
Actual mz234.113
Theoretical mz234.113
Error1.61
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.3644

Identifiers and class information

Inchi keyIDYPDRFMVHXYEC-HZDAAVBUSA-N
SmilesO=C(C=CC=CC1=CC=C2OCOC2=C1)C
SuperclassOrganoheterocyclic compounds
ClassBenzodioxoles

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)216.236
Computed dipole moment(dipole)3.082
Total solvent accessible surface area (SASA)452.564
Hydrophobic component of SASA (FOSA)213.809
Hydrophilic component of SASA (FISA)52.488
Pie component of the SASA (PISA)186.266
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)746.872
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)3.5
Free energy of solvation of dipole (dip^2/V)0.012715
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.879662
Predicted polarizability in cubic angstroms (QPpolrz)22.304
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.826
Predicted octanol/gas partition coefficient (QPlogPoct)8.62
Predicted water/gas partition coefficient (QPlogPw)4.777
Predicted octanol/water partition coefficient (QPlogPo/w)2.318
Predicted aqueous solubility (QPlogS)-2.147
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.516
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.367
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3148.85
Predicted brain/blood partition coefficient (QPlogBB)-0.19
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1709.2
Predicted skin permeability, log Kp (QPlogKp)-1.351
PM3 calculated ionization potential (IP(ev))8.816
PM3 calculated electron affinity (EA(eV))1.08
Number of likely metabolic reactions (#metab)0
Prediction of binding to human serum albumin (QPlogKhsa)-0.362
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)47.786
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P27338MAOBMonoamine oxidase BT83011SEA
Q8NER1TRPV1Vanilloid receptorT83193SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P20701ITGALIntercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2T35640SEA
P10276RARARetinoic acid receptor alphaT94085SEA
P05362ICAM1Intercellular adhesion molecule-1T26203SEA
Q15078CDK5R1Cyclin-dependent kinase 5/CDK5 activator 1T09513SEA
Q9Y463DYRK1BDual specificity tyrosine-phosphorylation-regulated kinase 1BT82720SEA
P25101EDNRAEndothelin receptor ET-AT23499SEA
Q00535CDK5Cyclin-dependent kinase 5/CDK5 activator 1T20973SEA
P17936IGFBP3Insulin-like growth factor binding protein 3T33455SEA
P24530EDNRBEndothelin receptor ET-BT92828SEA
Q92630DYRK2Dual-specificity tyrosine-phosphorylation regulated kinase 2T39486SEA
P19438TNFRSF1ATumor necrosis factor receptor R1T86552SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
P13631RARGRetinoic acid receptor gammaT82146SEA
P10826RARBRetinoic acid receptor betaT61657SEA
Q99527GPER1G-protein coupled estrogen receptor 1T65236SEA
P51843NR0B1Orphan nuclear receptor DAX-1T23191SEA
Q7RTX1TAS1R1Taste receptorT41263SEA
P05107ITGB2Integrin beta-2T10513SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T83193DI0163General pain disorder[ICD-11: 8E43]Q8NER1TRPV1
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T35640DI0351Psoriasis[ICD-11: EA90]P20701ITGAL
T35640DI0436Visual system disease[ICD-11: 9E1Z]P20701ITGAL
T94085DI0025Alzheimer disease[ICD-11: 8A20]P10276RARA
T94085DI0251Mature T-cell lymphoma[ICD-11: 2A90]P10276RARA
T26203DI0436Visual system disease[ICD-11: 9E1Z]P05362ICAM1
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T20973DI0308Obesity[ICD-11: 5B80-5B81]Q00535CDK5
T33455DI0115Dementia[ICD-11: 6D80-6D8Z]P17936IGFBP3
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB
T86552DI0060Brain cancer[ICD-11: 2A00]P19438TNFRSF1A
T86552DI0321Ovarian cancer[ICD-11: 2C73]P19438TNFRSF1A
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T82146DI0005Acne vulgaris[ICD-11: ED80]P13631RARG
T82146DI0012Acute myeloid leukaemia[ICD-11: 2A60]P13631RARG
T82146DI0225Kaposi sarcoma[ICD-11: 2B57]P13631RARG
T82146DI0277Muscle calcification/ossification[ICD-11: FB31]P13631RARG
T82146DI0351Psoriasis[ICD-11: EA90]P13631RARG
T61657DI0225Kaposi sarcoma[ICD-11: 2B57]P10826RARB
T65236DI0100Contraceptive management[ICD-11: QA21]Q99527GPER1
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1
T10513DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P05107ITGB2

Copyright © 2025